The third edition of the Women’s Health Investor Summit brought together more than 100 founders, investors, researchers, policymakers and industry leaders for an afternoon dedicated to accelerating investment and innovation in women’s health.

The programme opened with Sara Al-Dafaee, who welcomed participants and shared the Hub’s vision of building a stronger and more connected Nordic ecosystem for women’s health. She was followed by Kristine Leerbech, Founder & CEO of Angella Invest, and Katrina Feilberg, Industry Director for Health & Life Science at Dansk Erhverv, who highlighted why women’s health has become both a business opportunity and an economic priority.

One of the day’s key moments came from Malin Frithiofsson, CEO of Daya Ventures, whose keynote challenged the way women’s health is understood by investors. Her message was clear: women’s health is not a niche market - it is one of the largest untapped opportunities in healthcare.

The conversation continued with a panel debate on the future of risk-willing capital in women’s health, featuring Malin Frithiofsson, Fatiha Hessner Thiam, Sanne Brun Jensen, Ruth Brännvall and Lene Gerlach. Together, they explored what it will take to unlock more investment, strengthen early-stage funding and position the Nordics as a leading region for women’s health innovation.

The summit also showcased a wide range of startups tackling challenges across women’s health - from menopause and maternal care to diagnostics, pelvic health and AI-powered healthcare. The event concluded with networking, giving founders, investors and ecosystem partners the opportunity to continue the conversations and build new collaborations.

Thank you to everyone who joined us for another inspiring Women’s Health Investor Summit. We look forward to continuing the conversations and accelerating the future of women’s health together.